Archon Biosciences logo

Archon Biosciences

archon.bio

Archon Biosciences develops geometrically tunable protein therapeutics called Antibody Cages (AbCs), which integrate antibody affinity and specificity with generative protein design to target pathways inaccessible to other technologies. Its platform uses AI-driven structural engineering to create biologics with precise control over distribution, engagement, and function for improved treatment of disease. The organization aims to solve challenging drug discovery problems by advancing new classes of biologic medicines.

Facts

HQ
Seattle, Washington, US
Sectors
Biotechnology Research
Type
Corporation Seattle business license
Employees
26
Registered name
Archon Biosciences Inc Seattle business license
Stage
Seed

Is this your organization? Claim it

Founders

  • George Ueda
    George Ueda Chief Technology Officer, Co-Founder
  • James Lazarovits Chief Executive Officer, Co-Founder

Online